Weight loss management for overweight patient with weight-related comorbidity

This therapeutic indication represents a clinical intervention for adult patients classified as overweight, conventionally characterized by an elevated body mass index accompanied by at least one adiposity-driven medical condition These physiological changes commonly result in cardiometabolic, vascular, and biomechanical complications across cardiovascular, endocrine, and respiratory systems, notably hypertension, type 2 diabetes mellitus, dyslipidemia, or obstructive sleep apnea Weight loss man...

This therapeutic indication represents a clinical intervention for adult patients classified as overweight, conventionally characterized by an elevated body mass index accompanied by at least one adiposity-driven medical condition

Pathophysiologically, excess adipose tissue secretes pro-inflammatory cytokines, promotes chronic low-grade systemic inflammation, and contributes to insulin resistance and neuroendocrine dysregulation Weight loss management in this target population focuses on sustained reduction of excessive adiposity to mitigate comorbid disease severity, restore metabolic equilibrium, and reduce overall cardiovascular and metabolic risk

Pathophysiologically, excess adipose tissue secretes pro-inflammatory cytokines, promotes chronic low-grade systemic inflammation, and contributes to insulin resistance and neuroendocrine dysregulation

These physiological changes commonly result in cardiometabolic, vascular, and biomechanical complications across cardiovascular, endocrine, and respiratory systems, notably hypertension, type 2 diabetes mellitus, dyslipidemia, or obstructive sleep apnea